Sun Pharmaceutical Industries Limited — Board Meeting, 22-05-2026: Outcome of Board Meeting

Sun Pharma's Board approved Q4 & FY26 consolidated results. Q4 sales hit Rs 14,560 Cr, net profit Rs 2,714 Cr. FY26 sales reached Rs 58,220 Cr with net profit of Rs 11,479 Cr. A final dividend of Rs 5/share was proposed, making the total dividend Rs 16/share for FY26.